Figure 4

Representative images of U87MG tumour-bearing mice at pre-injection 14 d and 20 d after various treatments: (a) Control without any treatment, (b) Radiotherapy alone, (c) Radiotherapy and UCA with intravenous injection of UCA (70 mg Yb/kg), (d) Radiotherapy and UCA-RGD with intravenous injection of UCA-RGD (70 mg Yb/kg).(e, f) Growth of U87MG tumours from different groups after various treatments (n = 6).